Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… ACETAZOLAMIDE Capsule, Extended Release; 500MG DIAMOX DURAMED Barr 008943 ACETAZOLAMIDE Tablet; 125MG DIAMOX DURAMED Barr 008943 ACETAZOLAMIDE Tablet; 250MG DIAMOX DURAMED Barr 084840 ACETAZOLAMIDE Tablet; 250MG ACETAZOLAMIDE LANNETT 089752 ACETAZOLAMIDE Tablet; 125MG ACETAZOLAMIDE Mutual 089753 ACETAZOLAMIDE Tablet; 250MG ACETAZOLAMIDE Mutual 040195 ACETAZOLAMIDE Tablet; 125MG ACETAZOLAMIDE Taro 040195 ACETAZOLAMIDE Tablet; 250MG ACETAZOLAMIDE Taro 088882 ACETAZOLAMIDE Tablet; 250MG ACETAZOLAMIDE Watson 040108 ACETAZOLAMIDE SODIUM Injection 500MG BASE/VIAL ACETAZOLAMIDE SODIUM Abbott 040089 ACETAZOLAMIDE SODIUM Injection 500MG BASE/VIAL ACETAZOLAMIDE SODIUM Bedford 009388 ACETAZOLAMIDE SODIUM Injection 500MG BASE/VIAL DIAMOX DURAMED Barr | Diamox Sequels (acetazolamide) sustained-release capsules, Duramed Pharma, Manufacturing Change or Addition & Labeling Revision | Acetazolamide Extended-Release Capsules, Zydus Pharmaceuticals USA, Inc., Approval | Acetazolamide Sodium Injection, X-Gen Pharmaceuticals, Inc., Approval ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com